Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
4 Dec 2025
Evidence on VNS in the Modern DRE Treatment Landscape
In this interactive article, explore how drug-resistant epilepsy is linked to decreased quality of life and increased risk of morbidity and..
1
Mins
2 Dec 2025
Sputa Gram Stain for the Evaluation of
Staphylococcus aureus
and
Staphylococcus aureus
Pneumonia
Gram stain (GS) and BioFire® FilmArray® Pneumonia Panel (PN; Biomérieux, Marcy-l’Étoile, France) are rapid methods of detecting bacterial…
1
Mins
2 Dec 2025
Blood Culture Stewardship Reduced Skin Flora Contamination
Mycoplasma pneumoniae (MP) causes approximately two million infections in the USA, with increasing rates reported globally in the past…
2
Mins
2 Dec 2025
Development of a Severity Scoring System for
M. pneumoniae
Infection
Mycoplasma pneumoniae (MP) causes approximately two million infections in the USA, with increasing rates reported globally in the past few…
1
Mins
2 Dec 2025
Analysis of Positive Strongyloides Serology across Three Academic Centers
Strongyloides stercoralis is an intestinal parasitic nematode with a 2–7% prevalence in the USA. Immunosuppression can predispose to…
1
Mins
2 Dec 2025
Cumulative QTc Risk with Fluoroquinolone Prophylaxis
Fluoroquinolone (FQ) antibiotics are currently the acceptable therapy for spontaneous bacterial peritonitis (SBP) prophylaxis in selected…
1
Mins
1 Dec 2025
Characterisation of Natural Killer Cell Subsets in a Case of Sustained HIV Remission
Natural killer (NK) cells are increasingly studied in HIV cure research as certain subsets have been linked to natural HIV control…
12
Mins
1 Dec 2025
Review of the 20
th
European AIDS Clinical Society (EACS) Conference
THE 20th European AIDS Clinical Society (EACS) Conference opened its doors in Paris, France, from 15th–18th October 2025…
4
Mins
1 Dec 2025
Five Years to 2030: Europe’s Race to End the AIDS Epidemic
WITH ONLY 5 years remaining to meet the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2030 target of ending AIDS as a public…
1
Mins
1 Dec 2025
PrEP Continuity: Insights from Nigeria’s 2024 National Rollout
Despite the rapid expansion of oral pre-exposure prophylaxis (PrEP) services in Nigeria, programmatic data continue to highlight critical…
←
1
2
3
4
5
6
7
8
9
10
…
193
194
195
→
We’ve noticed you’re accessing
from
North/South America.
View
View